The findings indicated that DUB-IN-2 reduced the tumorigenic potential of breast cancer (Fig. 3L, N) and immunohistochemistry showed decreased Ki67 and YAP expression (Fig. 3O, P). This evidence concerns the gene MKI67 and breast cancer.